Dr. Amit Pande, PhD: Independent Scientific Reviewer

Author Biography

Dr. Amit Pande PhD, molecular biologist and independent scientific advisor at MediHealth PRODr. Amit Pande, PhD (Biotechnology) is a molecular biologist and researcher with over 15 years of hands-on experience in clinical research and high-complexity diagnostics. He has worked in senior diagnostic roles at Apollo Hospital, Medanta The Medicity, and Jaypee Hospital.

He currently works as a Senior Diagnostic Manager at a leading healthcare institution in India, where he applies his background in molecular diagnostics and clinical research every day.

Since 2025, Dr. Pande has been the Independent Scientific Reviewer for MediHealth PRO. He checks every article for scientific accuracy and makes sure the information published here reflects real clinical evidence, not just general health advice.

Academic Credentials & Professional Training

Dr. Pande’s advanced specialization allows him to analyze health claims at the molecular and cellular levels—the foundational science behind every article on this platform.

Core Expertise

Dr. Pande brings over 15 years of clinical diagnostic experience to every article he reviews. His work focuses on finding the biological reasons behind everyday health concerns, particularly in children.

1. Immunology & Transplantation

Dr. Pande has hands-on experience assessing immune responses and transplant rejection risks using Luminex xMAP and Thermo Fisher (One Lambda) technologies to analyze HLA antibodies and Donor-Specific Antibodies (DSA).

This background is directly relevant to understanding immune system development, autoimmune conditions, and chronic inflammatory disorders in children.

2. Hematology & Transfusion Medicine

His clinical work includes leucodepletion, antigen-antibody reaction analysis, and transfusion-related alloimmunization, with a focus on how blood-based cellular changes affect immunity and long-term health.

This background is useful for explaining iron deficiency, blood biomarkers, and how cellular changes affect child development and cognitive function.

3. Genomics & Molecular Diagnostics

Dr. Pande works with Next-Generation Sequencing (NGS) and Real-Time PCR (qPCR) via Roche systems to interpret genomic data and provide precise diagnostic insights.

This expertise supports the site’s coverage of genetic factors behind ADHD, autism, and neurodevelopmental conditions in children.

4. Cell Signaling, Endocrinology & Biochemistry

Dr. Pande studies the biochemical pathways and hormonal signals that control how cells communicate with each other. This background helps explain how metabolic balance, stress response, and endocrine function affect everyday health.

Relevant for understanding how hormones influence child behavior, mood regulation, and ADHD symptoms.

5. Microbiology & The Microbiome

Dr. Pande studies microbial communities and how they influence gut health, chronic inflammation, and immune function.

Relevant for understanding how gut health affects child immunity, brain development, and behavioral outcomes.

6. Regenerative Medicine

His experience includes stem cell biology, with a focus on characterizing hematopoietic stem cells (CD34+) and monitoring immune recovery through T-cell subset analysis (CD3, CD4, and CD8).

Relevant for explaining cellular recovery, immune development, and long-term health outcomes in children.

7. Clinical Research & Data

Dr. Pande applies ISO 15189 standards to interpret complex molecular data, separating clinically proven findings from common health myths.

Every article reviewed on MediHealth PRO goes through this process before publication.

Verifiable Authority: Peer-Reviewed Publications

Dr. Pande has authored or co-authored over 50 peer-reviewed international research papers in specialized fields such as Renal Transplantation and Transfusion Medicine. This extensive publication record establishes the scientific integrity and rigor he brings to every article reviewed on MediHealth PRO.

All publications listed below are independently verifiable through international research databases.

Selected Publications & Research Portfolio

  • A retrospective observational study to estimate the risk of HLA alloimmunization with blood transfusion: Can the risk be reduced by leucodepletion? Immunobiology. 2023. View on ScienceDirect ↗︎
  • Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases. Transpl Immunol, 2023. View on PubMed ↗︎
  • Effects of Different Sensitization Events on HLA Alloimmunization in Renal Transplant Cases; a Retrospective Observation in 1066 Cases. Transplant Immunology, 2022. View on PubMed ↗︎
  • A Case of Successful Desensitization in High Risk HLA Incompatible Kidney Transplantation. Indian J Nephrol, 2021. View on Science Direct ↗︎
  • Clinical outcome of living donor kidney transplantation across simultaneous ABO and HLA incompatibility: Single center experience of first ten cases. Transfus Apher Sci, 2021. View on PubMed ↗︎
  • Desensitization Therapy in Kidney Transplantation Cases with Positive Baseline Complement-Dependent Cytotoxicity Crossmatch and High Donor-Specific Antibodies: A Retrospective Study. Indian Journal of Transplantation, 2021. Indian Journal of Transplantation ↗︎
  • Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants. J Clin Apher, 2021. Journal of Clinical Apheresis ↗︎
  • Comparative Study for Measurement of Residual Leucocytes in Leuco-depleted Red Blood Cells by Two Different Methods. Indian journal of hematology and blood transfusion, 2020. View on PubMed ↗︎
  • Extraoral plasmablastic lymphoma detected using ascitic fluid cytology and flow cytometry: a case report with a review of the literature. Acta Cytol. 2014;58(3):309-17. View on PubMed ↗︎
  • Stability of eosin-5′-maleimide dye used in flow cytometric analysis for red cell membrane disorders. Blood Res. 2015 Jun;50(2):109-12. View on PubMed ↗︎
  • CD5 positive hairy cell leukemia: A rare case report with brief review of literature. Cytometry B Clin Cytom. 2016 Sep;90(5):467-72. View on PubMed ↗︎
  • Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia. Indian J Pathol Microbiol. 2016 Jul-Sep;59(3):310-3. View on PubMed ↗︎
  • Hepatosplenic T Cell Lymphoma in an Immunocompetent Female Diagnosed using flow cytometry: A Rare Clinical Entity. J Clin Diagn Res. 2016 Aug;10(8):ED15-6. View on PubMed ↗︎
  • Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2015 Sep-Oct;88(5):348-51. View on PubMed ↗︎

Verifiable Research Profiles

To view Dr. Pande’s complete research history, please visit his official profiles:

Connect With Dr. Amit Pande, PhD

Medical Disclaimer:

The content on MediHealth PRO is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you have concerns about your child’s development or health, please consult a qualified pediatrician or healthcare professional.